pecan
Allergenexperimental
Clinical trial activity
7 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 10, 2017 (NCT04849962)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, desensitized
Immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSF14P91GB5F ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06879626 | N/A | Apr 1, 2025 | University of California, Los Angeles |
| NCT05949879 | N/A | Aug 1, 2023 | University of Georgia |
| NCT05071807 | Phase 2 | Jan 31, 2022 | American Pecan Council, Pennsylvania State University |
| NCT04487808 | Phase 2 | May 1, 2021 | Pennsylvania State University |
| NCT04385537 | N/A | Jun 1, 2020 | American Pecan Council, University of Georgia |
| NCT04376632 | N/A | Aug 10, 2018 | Georgia Pecan Commission, University of Georgia |
| NCT04849962 | N/A | Aug 10, 2017 | University of Georgia |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Georgia | Academic/Hospital | 4 | 4 | 1 | 2017 |
| American Pecan Council | For profit | 2 | 0 | 2 | 2020 |
| Pennsylvania State University | Academic/Hospital | 2 | 2 | 1 | 2021 |
| Georgia Pecan Commission | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2025 |
5 organizations
Page 1 / 1